SCHEMBL8034718

SCHEMBL8034718

C=Cc1cc(O)ccc1-c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.40
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
CHEK1 O14757 1/20 0.38
WEE1 P30291 1/20 0.38
RPS6KB2 Q9UBS0 1/20 0.37
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TMIGD3 P0DMS9 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
MEN1 O00255 2/20 0.36
GAA P10253 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GLA P06280 1/20 0.36
POLB P06746 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21357357 0.82 ERN1 (0.39) ERN1RPS6KB2MAPTTMIGD3ADORA2A
SCHEMBL6067982 0.78 MAPT (0.47) ERN1ESR1ESR2CHEK1WEE1
SCHEMBL1823432 0.77 LTA4H (0.43) RPS6KB2MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL8034332 0.76 MAOB (0.48) ERN1MAPTSMN1; SMN2MEN1GAA
SCHEMBL7157852 0.74 ESR1 (0.57) ERN1ESR1ESR2CHEK1WEE1
SCHEMBL27752649 0.74 ESR2 (0.61) ERN1ESR1ESR2MAPTSMN1; SMN2
SCHEMBL19153623 0.73 ERN1 (0.54) ERN1ESR1ESR2CHEK1WEE1
Cyanide SCHEMBL28839538 0.72 LTA4H (0.40) MAPTSMN1; SMN2MEN1GAAKMT2A
SCHEMBL32674544 0.72 ALOX5 (0.59) ESR1ESR2KMT2AMIFNPC1
SCHEMBL28489946 0.71 TNFRSF1A (0.37) ERN1RPS6KB2MAPTADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009076166-A2 OXIMYL HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-18 WO disclosed
WO-2009076173-A2 FLUORINATED TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-18 WO disclosed
WO-2007146695-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2007-12-21 WO disclosed